Why Objective Pain Assessment Matters?
Pain affects quality of life for millions of patients. Treating pain is at the heart of medicine and is an essential role of every healthcare provider, as unmanaged pain delays recovery, increases morbidity and mortality, and overburdens healthcare resources. Pain is the most common reason for medical consultation; 30% of adults suffer from chronic pain, and the direct annual healthcare costs associated with pain exceed $600 billion worldwide.
Despite the prevalence of pain, there are currently no clinically accepted tools to objectively assess pain. This requires physicians to rely on patients’ subjective assessments, or to simply guess when patients cannot describe their pain (sedated/babies/demented etc.). There is a general consensus that an objective assessment of pain will revolutionize pain management, contribute to better clinical outcomes; accelerate recovery; and minimize complications, adverse events, and their associated costs.
Medasense Biometrics - Our Story.
Finding Your "Signature of Pain"
Medasense’s technology combines a sensing unit (connected to a patient) that records multiple pain-related physiological signals, with a monitor that uses an artificial intelligent algorithm to determine an individual’s “signature of pain”. The pain level is presented as a single number on a scale of 0 to 100 (100 = extreme pain) on the Medasense NoL Index.
Considering the complex nature of pain, the Medasense technology collects and analyses multiple pain-related physiological parameters and their time derivatives, and converts them into a single pain index, for superior pain assessment.
Based on advanced statistical modelling and data anlysis, Medasense's proprietary algorithm is able to process multiple pain-related physiological parameters and discover their complicated nonlinear relation to pain.
Results from multiple clinical studies during surgery, published in leading medical journals confirm Medasense’s superior pain assessment technology over currently used methods and parameters.
Our latest news
For the full review, please click here
Israeli anesthesiologists are now able to join their European colleagues, who are already using our technology , to optimize and personalize the intraoperative analgesic administration.
This is a significant milestone for Medasense. We are very proud to enter our home market, where our technology was developed!